Navigation Links
Malaria Control Method Could Prevent 6 Million New Infant Cases
Date:9/16/2009

BARCELONA, Spain, September 17 /PRNewswire/ -- A third (30%) of malaria cases can be avoided in African infants using a safe, affordable and simple tool called Intermittent Preventive Treatment of malaria in Infants (IPTi) with the medicine sulphadoxine-pyrimethamine (SP), which can be delivered alongside existing childhood vaccination programmes.(i) Results of a meta-analysis examining six clinical trials in Africa for the malaria intervention which the World Health Organization already recommends are published online today in the medical journal, The Lancet. Research experts say if IPTi-SP were expanded in other African countries, 6 million cases of malaria could be prevented each year in those most vulnerable to the disease.(ii,iii)

"These results confirm the potential for IPTi using SP, which can be easily and rapidly implemented via existing WHO immunisation programmes, saving tens of thousands of lives every year across Africa", commented Dr Pedro Alonso, a principal investigator and head of the Secretariat at the Barcelona Centre for International Health Research, Hospital Clinic, University of Barcelona, Spain. "IPTi provides a valuable addition to efforts to fight malaria and so international policy-makers and heads of national Malaria Control Programmes should consider its immediate adoption and integration into existing programmes," he added.

Organised by the IPTi Consortium and supporting partners - a unique collaboration of more than 20 organisations in Africa, Europe and the United States - the pooled analysis of six randomised, placebo-controlled trials of IPTi-SP in Africa provides the best evidence to date that this approach is effective in preventing malaria in infants. The study analysed results from nearly 8,000 infants, in four African countries, over nine years, between 1999-2008. The efficacy results were re-analysed by the statistician of each of the six trials, and an independent panel made up of experts in safety and pharmacovigilance in Africa conducted an analysis of the safety. The IPTi Consortium is supported by the Bill & Melinda Gates Foundation.

Malaria represents an important public health burden in Africa, disproportionately affecting the youngest and most vulnerable. Of the 247 million cases of malaria worldwide in 2006, 86% occurred in Africa.(ii) African infants are most at risk of the worst forms of malaria, every 30 seconds an African child dies from malaria.(iv)

About IPTi

IPTi is the administration of an anti-malarial tablet to infants, two or three times in the first year of life, deliverable alongside established vaccination programmes such as WHO's Expanded Programme for Immunisation. It is inexpensive (each dose costs between USD $0.13 - $0.23)(v,vi) and cost effective. IPTi with SP has been reviewed by a committee of the US National Academy of Sciences' Institute of Medicine and the World Health Organization's Technical Expert Group - these committees recommend that it should be considered for implementation in areas of moderate to high levels of malaria transmission and low to moderate levels of parasite resistance to SP.(vii,viii)

Complete release with references may be found on http://www.ipti-malaria.org


'/>"/>
SOURCE IPTi Consortium
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Enhance Efficiency and Scale-up of its Malaria Vaccine Manufacturing Process
2. Fox Soccer Channel and Fox Sports en Espanol Renew Every Goal Saves A Life Campaign With Malaria No More
3. Nothing But Nets Teams Up With Boy Scouts of America to Fight Malaria
4. LSTM to lead EU project to coordinate antimalarial drug research
5. Resistance to Malaria Drug Reported in Cambodia
6. GenVec Receives Grant for Malaria Vaccine Program
7. PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach
8. Counterfeit antimalarial drug discovered in Ghana
9. New global subsidy for malaria medicines must ensure quality of care
10. Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz
11. Global Fund Increases AIDS, Tuberculosis and Malaria Prevention and Treatment Measures by 30-50% Over One Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: